National Alliance for the Mentally Ill http://www.nami.org/
National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/
Canadian Mental Health Association http://www.ontario.cmha.ca/index.asp/
Mental Health Canada http://www.mentalhealthcanada.com/
Bai YM, Yu SC, Lin CC.
Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
J Clin Psychiatry
Bradley WG, Daroff RB, Fenichel G, Jankovic J.
Neurology in Clinical Practice.
4th ed. Butterworth Heinemann; 2003. Available at:
. Accessed November 4, 2007.
Cecil RL, Goldman L, Bennett JC.
Cecil Textbook of Medicine.
21st ed. Philadelphia, PA: WB Saunders Co; 2000.
Conn HF, Rakel RE.
Conn's Current Therapy 2001.
53rd ed. Philadelphia, PA: WB Saunders Co; 2001.
Griffith's 5-Minute Clinical Consult.
Baltimore, MD: Lippincott Williams & Wilkins; 2001.
Kinon BJ, Jeste DV, Kollack-Walker S, Stauffer V, Liu-Seifert H.
Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods.
Prog Neuropsychopharmacol Biol Psychiatry
McGrath JJ, Soares KV. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
Database Syst Rev
Meco G, Fabrizio E, Epifanio A, et al. Levetiracetam in tardive dyskinesia.
Primary Care Medicine.
4th ed. Lippincott Williams & Wilkins; 2000.
Philadelphia, PA: WB Saunders Co; 1997.
Sachdev PS. The current status of tardive dyskinesia.
Australian and New Zealand Journal of Psychiatry.
Tardive dyskinesia. DynaMed website. Available at:
. Updated January 2009. Accessed February 11, 2009.
Noble J, Greene HL.
Textbook of Primary Care Medicine.
3rd ed. St. Louis, MO: Mosby Inc; 2001.
Thema B, Srivastava V, Tiwari AK. Genetic underpinnings of tardive dyskinesias: passing the baton to pharmacogenetics.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.
Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.